Skip to main content
. 2023 Jul 18;101(3):e238–e252. doi: 10.1212/WNL.0000000000207402

Table 4.

Adverse Events for Participants in the Elamipretide and Placebo Groups

graphic file with name WNL-2023-000248t4.jpg